Spero Therapeutics, Inc. (SPRO) vs Tenax Therapeutics, Inc. (TENX)
- Spero Therapeutics, Inc. SPRO 1.04 +1.96%
- Tenax Therapeutics, Inc. TENX 1.69 +3.68%
Spero Therapeutics, Inc. and Tenax Therapeutics, Inc. are both Biotechnology companies. Spero Therapeutics, Inc. and Tenax Therapeutics, Inc. are of similar size ($61.0M and $59.4M). Tenax Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Spero Therapeutics, Inc. trades at 7.4×. Spero Therapeutics, Inc. grew revenue faster over the last twelve months: 37.2% against −70.8%. Across the 14 metrics below, Spero Therapeutics, Inc. leads on 10 and Tenax Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | SPRO | TENX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 19.17% | (59.80%) | (51.96%) |
| Return on assets | 12.85% | (57.02%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack